These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 20933608

  • 21. Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone.
    Brembilla-Perrot B, Claudon O, Houriez P, Beurrier D, Suty-Selton C.
    Int J Cardiol; 2002 Apr; 83(1):47-55. PubMed ID: 11959384
    [Abstract] [Full Text] [Related]

  • 22. Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification.
    Zorzi A, Migliore F, Elmaghawry M, Silvano M, Marra MP, Niero A, Nguyen K, Rigato I, Bauce B, Basso C, Thiene G, Iliceto S, Corrado D.
    J Cardiovasc Electrophysiol; 2013 Dec; 24(12):1321-7. PubMed ID: 24016194
    [Abstract] [Full Text] [Related]

  • 23. Use of signal-averaged electrocardiography in the evaluation of arrhythmogenic right ventricular cardiomyopathy in boxers.
    Spier AW, Meurs KM.
    J Am Vet Med Assoc; 2004 Oct 01; 225(7):1050-5. PubMed ID: 15515982
    [Abstract] [Full Text] [Related]

  • 24. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy.
    Roudijk RW, Verheul L, Bosman LP, Bourfiss M, Breur JMPJ, Slieker MG, Blank AC, Dooijes D, van der Heijden JF, van den Heuvel F, Clur SA, Udink Ten Cate FEA, van den Berg MP, Wilde AAM, Asselbergs FW, Peter van Tintelen J, Te Riele ASJM.
    JACC Clin Electrophysiol; 2022 Mar 01; 8(3):306-318. PubMed ID: 35331425
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Biventricular myocardial strain analysis using cardiac magnetic resonance feature tracking (CMR-FT) in patients with distinct types of right ventricular diseases comparing arrhythmogenic right ventricular cardiomyopathy (ARVC), right ventricular outflow-tract tachycardia (RVOT-VT), and Brugada syndrome (BrS).
    Heermann P, Fritsch H, Koopmann M, Sporns P, Paul M, Heindel W, Schulze-Bahr E, Schülke C.
    Clin Res Cardiol; 2019 Oct 01; 108(10):1147-1162. PubMed ID: 30868222
    [Abstract] [Full Text] [Related]

  • 27. Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia.
    Saberniak J, Leren IS, Haland TF, Beitnes JO, Hopp E, Borgquist R, Edvardsen T, Haugaa KH.
    Eur Heart J Cardiovasc Imaging; 2017 Jan 01; 18(1):62-69. PubMed ID: 26903598
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Usefulness of T(peak) -T(end) interval to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic right ventricular outflow tract tachycardia.
    Golcuk E, Yalin K, Kaya Bilge A, Elitok A, Aksu T, Akgun T, Bilal Karaayvaz E, Emet S, Adalet K.
    Pacing Clin Electrophysiol; 2014 Dec 01; 37(12):1665-70. PubMed ID: 25041179
    [Abstract] [Full Text] [Related]

  • 30. [Clinical and ECG features of arrhythmogenic right ventricular cardiomyopathy: a retrospective analysis of 31 cases].
    Pu JL, Wang HT, Liu TK, Ma KJ, Li N, Yao Y, Chu JM, Fang PH, Ma J, Hua W, Zhang S, Wang FZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan 01; 35(1):24-7. PubMed ID: 17386159
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy.
    Mancini DM, Wong KL, Simson MB.
    Circulation; 1993 Apr 01; 87(4):1083-92. PubMed ID: 8462136
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inability of the signal-averaged electrocardiogram to determine risk of arrhythmia recurrence in patients with implantable cardioverter defibrillators.
    Epstein AE, Dailey SM, Shepard RB, Kirk KA, Kay GN, Plumb VJ.
    Pacing Clin Electrophysiol; 1991 Jul 01; 14(7):1169-78. PubMed ID: 1715554
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of the 2010 task force criteria on reclassification of cardiovascular magnetic resonance criteria for arrhythmogenic right ventricular cardiomyopathy.
    Liu T, Pursnani A, Sharma UC, Vorasettakarnkij Y, Verdini D, Deeprasertkul P, Lee AM, Lumish H, Sidhu MS, Medina H, Danik S, Abbara S, Holmvang G, Hoffmann U, Ghoshhajra BB.
    J Cardiovasc Magn Reson; 2014 Jul 04; 16(1):47. PubMed ID: 24996808
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of revised Task Force Criteria: distinguishing the athlete's heart from ARVC/D using cardiac magnetic resonance imaging.
    Luijkx T, Velthuis BK, Prakken NH, Cox MG, Bots ML, Mali WP, Hauer RN, Cramer MJ.
    Eur J Prev Cardiol; 2012 Aug 04; 19(4):885-91. PubMed ID: 21690305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.